Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XR-NTX vs XR-B in Individuals Leaving Jail
NCT04408313Phase 3Active, not recruiting
- Sponsor
- Friends Research Institute
- Start
- Oct 2020
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine extended-release injection, naltrexone in opioid use disorder (OUD), sponsored by Friends Research Institute. Started Oct 2020; status: active, not recruiting.
02
Drugs
buprenorphine extended-release injectionnaltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04408313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04408313.